EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY-NC-ND 4.0

Iterative intraoperative 3T MRI (iMRI)-guided brachytherapy: A prospective study on enhancing implantation precision and dosimetric gains in advanced gynecologic cancers

Shrikiriti S Rajan, Matthew S Ning, Megan Jacobson, Samantha J Simiele, Teresa Bruno, Ramez Kouzy, Kyoko Yoshida-Court, Tatiana Cisneros-Napravnik, Henry Yu, Jason Stafford, Yusung Kim, Geena Mathew und 9 weitere

Brachytherapy · 2025

DOI: 10.1016/j.brachy.2025.06.010 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Brachytherapy, 2025. Verfasst von Shrikiriti S Rajan und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Iowa Health Care, USA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer C…. Hauptthemen laut MEDLINE: Brachytherapy, Radiotherapy, Image-Guided, Uterine Cervical Neoplasms, Genital Neoplasms, Female. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Cancer Institute, Radiological Society of North America, University of Texas MD Anderson Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To report on primary outcomes and dosimetric results of a prospective clinical trial and protocol for use of iterative intraoperative magnetic resonance imaging (iMRI) in gynecologic brachytherapy. METHODS: Patients with locally advanced cervical or vaginal cancer (FIGO stages IB2 - IVA, and stage II-IVA, respectively) undergoing pulsed dose rate (PDR) brachytherapy were enrolled in a prospective clinical trial (NCT03634267) using iterative 3T iMRI during brachytherapy implant placement. Applicator and optional interstitial needles were placed under iMRI guidance in a 3T clinical MRI scanner. Imaging, dosimetry and clinical outcomes (local control (LC), recurrence-free survival (RFS), overall survival (OS)), and acute and long-term toxicity were evaluated prospectively and confirmed by chart review. To explore dosimetric gains, an EQD2 estimate comparing iMRI-guidance versus standard of care guidance, as well as a 3-patient analysis of dose changes with iMRI-guided optimization was included. RESULTS: Fourteen patients underwent iMRI-guided brachytherapy. Seventy percent (70%) of patients presented with FIGO stage III disease or higher. Median follow-up was 44 months. . Patients had 2-year median LC, RFS, and OS rates of 83.3%, 76%, and 84.6%, respectively. Acute toxicities were minimal with one (1) case of grade 3 nausea. No grade 3 or higher long-term toxicities were observed. Median operating room (OR) time was 283 minutes (range 174-380 mins). On exploratory analysis, implant placement performed with iMRI guidance demonstrated higher HR-CTV D90 doses (mean difference of +784.7 cGy, p = NS) were achieved compared to US and CT guided implantation in the same patients. DISCUSSION: iMRI-guidance for gynecologic brachytherapy is safe, associated with minimal high-grade toxicity and excellent clinical outcomes. Future studies to optimize resource use, image acquisition efficiency, and identifying predictive imaging features are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrachytherapyRadiotherapy, Image-GuidedUterine Cervical NeoplasmsGenital Neoplasms, FemaleMagnetic Resonance ImagingMagnetic Resonance Imaging, InterventionalHumansFemaleProspective StudiesMiddle AgedAgedAdultRadiotherapy Dosage

Stichwörter der Autor:innen

Brachytherapy implantCervical cancerImage guidanceIntraoperative MRIPulsed dose rate (PDR)Vaginal cancer

Autor:innen und Institutionen

  • Department of Radiation Oncology, University of Iowa Health Care, USA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, USA. Electronic address: ssrajan@uiowa.edu.
  • Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, USA.
  • Department of Radiation Oncology, University of Alabama at Birmingham, USA.
  • Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, USA.
  • Department of Radiology, The University of Texas MD Anderson Cancer Center, USA.

Förderung

  • National Cancer Institute
  • Radiological Society of North America
  • University of Texas MD Anderson Cancer Center
  • Merck
  • RSNA Research and Educational Foundation
  • National Institutes of Health

Zitieren

APA

Rajan, S. S., Ning, M. S., Jacobson, M., Simiele, S. J., Bruno, T., Kouzy, R., Yoshida-Court, K., Cisneros-Napravnik, T., Yu, H., Stafford, J., Kim, Y., Mathew, G., Cordova, R. A., Domingo, M., Jhingran, A., Lin, L. L., Joyner, M., Sims, T. T., Colbert, L., …, & Klopp, A. (2025). Iterative intraoperative 3T MRI (iMRI)-guided brachytherapy: A prospective study on enhancing implantation precision and dosimetric gains in advanced gynecologic cancers. Brachytherapy. https://doi.org/10.1016/j.brachy.2025.06.010

Vancouver

Rajan SS, Ning MS, Jacobson M, Simiele SJ, Bruno T, Kouzy R, et al. Iterative intraoperative 3T MRI (iMRI)-guided brachytherapy: A prospective study on enhancing implantation precision and dosimetric gains in advanced gynecologic cancers. Brachytherapy. 2025. doi:10.1016/j.brachy.2025.06.010

BibTeX
@article{Rajan2025,
  author = {Rajan, Shrikiriti S and Ning, Matthew S and Jacobson, Megan and Simiele, Samantha J and Bruno, Teresa and Kouzy, Ramez and Yoshida-Court, Kyoko and Cisneros-Napravnik, Tatiana and Yu, Henry and Stafford, Jason and Kim, Yusung and Mathew, Geena and Cordova, Rauda Alicia and Domingo, Maliah and Jhingran, Anuja and Lin, Lilie L and Joyner, Melissa and Sims, Travis T and Colbert, Lauren and Venkatesan, Aradhana M and Klopp, Ann},
  title = {Iterative intraoperative 3T MRI (iMRI)-guided brachytherapy: A prospective study on enhancing implantation precision and dosimetric gains in advanced gynecologic cancers},
  journal = {Brachytherapy},
  year = {2025},
  doi = {10.1016/j.brachy.2025.06.010}
}
Kostenlos starten →